// App-Quantinova.ai

: Low Molecular Weight Heparin (LMWH) for Venous Thromboembolism (VTE) Prophylaxis in Patients with Primary Central Nervous System Lymphoma (PCNSL)

Researchers

Presenter

  • Deborah Rund

Principal Investigators

  • Stav Gazal

  • Yosef Kalish

  • Chen Makranz

  • Neta Goldschmidt

Medical Centers

  • Hematology Department, Hadassah University Hospital Ein Kerem, Jerusalem, Israel

  • Hebrew University- Hadassah Medical Center, Jerusalem, Israel

  • Hematology Department, Hadassah University Hospital Ein Kerem, Jerusalem, Israel

  • Hematology Department, Hadassah University Hospital Ein Kerem, Jerusalem, Israel

Locations

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Primary central nervous system lymphoma

  • Venous thrombosis

  • Congestive heart failure

  • Lymphomas

  • Diabetes

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved